Idexx Laboratories (IDXX) said Wednesday that its Cancer Dx Panel for early detection of canine lymphoma is now available in the United Kingdom.
The company said that the blood test can be added to panels for sick pets and integrated into regular wellness screenings.
It said that pricing will begin at 22.50 pounds ($29.9) and that results will be available to UK practices within three to five business days.
Idexx said it plans to expand the Cancer Dx Panel over the next three years to cover the majority of canine cancer cases.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments